Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.
MER Indicator |
MER description |
Target Fiscal Year |
Target |
CARE_CURR |
Age/sex: 15-19 Female |
2016 |
142 |
CARE_CURR |
Age/sex: 15-19 Female |
2016 |
142 |
CARE_CURR |
Age/sex: 15-19 Male |
2016 |
95 |
CARE_CURR |
Age/sex: 15-19 Male |
2016 |
95 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
4,260 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female |
2016 |
142 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
2,850 |
CARE_CURR |
Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male |
2016 |
95 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
7,347 |
CARE_CURR |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
237 |
CARE_CURR |
Sum of Age/Sex disaggregates |
2016 |
237 |
CARE_CURR |
Sum of Age/Sex disaggregates |
2016 |
237 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
7,110 |
CARE_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
237 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
15,128 |
HTS_TST |
Number of individuals who received T&C services for HIV and received their test results during the past 12 months |
2016 |
488 |
HTS_TST |
Sum of Test Result disaggregates |
2016 |
98 |
HTS_TST_POS |
By Test Result: Positive |
2016 |
98 |
PP_PREV |
Age/sex: 15-19 Female |
2016 |
4,092 |
PP_PREV |
Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period |
2016 |
4,692 |
PP_PREV |
Sum of Age/Sex disaggregates |
2016 |
4,092 |
PP_PREV |
Total number of people in the target population |
2016 |
216,857 |
TB_SCREEN |
Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load |
2016 |
7,347 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2016 |
2,697 |
TX_CURR |
Aggregated Age/Sex: 15+ Female |
2016 |
86 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2016 |
1,767 |
TX_CURR |
Aggregated Age/Sex: 15+ Male |
2016 |
57 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2016 |
4,464 |
TX_CURR |
Number of adults and children receiving antiretroviral therapy (ART) |
2016 |
144 |
TX_CURR |
Sum of age/sex disaggregates |
2016 |
143 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2016 |
4,464 |
TX_CURR |
Sum of Aggregated Age/Sex 15+ |
2016 |
143 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
4,464 |
TX_CURR |
Sum of Aggregated Age/Sex disaggregates |
2016 |
143 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Female |
2016 |
53 |
TX_NEW |
Aggregated Grouping by Age/Sex: 15+ Male |
2016 |
35 |
TX_NEW |
By Age/Sex: 15-19 Female |
2016 |
53 |
TX_NEW |
By Age/Sex: 15-19 Male |
2016 |
35 |
TX_NEW |
Number of adults and children newly enrolled on antiretroviral therapy (ART) |
2016 |
88 |
TX_NEW |
Sum of Age/Sex disaggregates |
2016 |
88 |
TX_NEW |
Sum of Aggregated Age/Sex disaggregates |
2016 |
88 |